Asian stocks increased on U.S. rate cut anticipation and French elections blocking Marine Le Pen’s far-right. S&P 500 futures fell 0.1%, dollar weakened by U.S. jobs report. Earnings season approaches with Citigroup, JP Morgan, Well Fargo reporting. Investors expect September rate cuts, Treasury yields down, gold prices high. Fed Chair’s testimony, German inflation, U.S. consumer price report, oil prices awaited.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,
June 1, 2026